2009
DOI: 10.1186/1746-1596-4-8
|View full text |Cite
|
Sign up to set email alerts
|

On the significance of Surfactant Protein-A within the human lungs

Abstract: Surfactant Protein-A (SP-A) is the most prominent among four proteins in the pulmonary surfactant-system. SP-A is expressed by alveolar epithelial cells type II as well as by a portion of non small cell lung carcinomas (NSCLC).The expression of SP-A is complexly regulated on the transcriptional and the chromosomal level. SP-A is a major player in the pulmonary cytokine-network and moreover has been described to act in the pulmonary host defense.By the use of cell culture or animal models the functional propert… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 36 publications
0
19
0
Order By: Relevance
“…Reduced SP-A expression in lungs after embolism might be caused by the limited number of SP-A producing type II cells and/or by a reduced SP-A expression of the remaining - uninjured cells - similarly to the lung fibrosis [11]. …”
Section: Surfactant-specific Protein a (Sp-a)mentioning
confidence: 99%
“…Reduced SP-A expression in lungs after embolism might be caused by the limited number of SP-A producing type II cells and/or by a reduced SP-A expression of the remaining - uninjured cells - similarly to the lung fibrosis [11]. …”
Section: Surfactant-specific Protein a (Sp-a)mentioning
confidence: 99%
“…Previous study show that secretions Surfactant Protein-A (SP-A) are described to useful for the diagnostics of pulmonary edema and it plays a significant role on the human pulmonary disorders and lung diseases [39]. Mechanistically, it is understandable why AQP5 should not facilitate the alveolar-capillary integrity.…”
Section: Discussionmentioning
confidence: 99%
“…Entities like bronchiolocentric interstitial pneumonia [45], idiopathic bronchiolitis [46-48] or inhaled drug induced ILD [49], have to be excluded histologically and clinically. Further aspects in diagnosis, prognosis and therapy of IP will be offered by systemic biology [50], surfactant expression and immunohistochemistry [51,52], and genetics [53]. …”
Section: Discussionmentioning
confidence: 99%